Universe · entity

5AM Venture Management, LLC

Institutional manager (13F) · CIK 1799883
13F holdings · as of 2026-03-31 · top 20 · reported portfolio $360M
#IssuerValueShares
1ERASCA INC$56M3,485,971
2ENTRADA THERAPEUTICS INC$51M4,056,379
3TYRA BIOSCIENCES INC$39M1,029,298
4CAMP4 THERAPEUTICS CORP$26M5,869,091
5CENTESSA PHARMACEUTICALS PLC$23M580,945
6PHARVARIS N V$23M797,600
7MAPLIGHT THERAPEUTICS INC$19M950,011
8TECTONIC THERAPEUTIC INC$19M606,660
9CELLDEX THERAPEUTICS INC NEW$16M497,270
10ARTIVA BIOTHERAPEUTICS INC$15M2,353,304
11EYEPOINT INC$14M1,050,000
12SURROZEN INC$11M387,500
13ZENTALIS PHARMACEUTICALS INC$9M3,947,913
14GH RESEARCH PLC$8M572,665
15PROTARA THERAPEUTICS INC$7M1,369,782
16BIOHAVEN LTD$6M738,972
17ALX ONCOLOGY HLDGS INC$6M3,057,325
18SKYE BIOSCIENCE INC$6M9,681,763
19RALLYBIO CORP$3M291,788
20SILENCE THERAPEUTICS PLC$3M476,200
All filings on EDGAR ↗

Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.